These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 30249696)

  • 1. Electrocardiographic Safety of Repeated Monthly Dihydroartemisinin-Piperaquine as a Candidate for Mass Drug Administration.
    Millat-Martínez P; Ila R; Laman M; Robinson L; Karunajeewa H; Abel H; Pulai K; Sanz S; Manning L; Moore B; Bassat Q; Mitjà O
    Antimicrob Agents Chemother; 2018 Dec; 62(12):. PubMed ID: 30249696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Piperaquine Pharmacokinetic and Pharmacodynamic Profiles in Healthy Volunteers of Papua New Guinea after Administration of Three-Monthly Doses of Dihydroartemisinin-Piperaquine.
    Millat-Martínez P; Salman S; Moore BR; Baro B; Page-Sharp M; Batty KT; Robinson LJ; Pomat W; Karunajeewa H; Laman M; Manning L; Mitjà O; Bassat Q
    Antimicrob Agents Chemother; 2022 Aug; 66(8):e0018522. PubMed ID: 35862743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized, double-blind, placebo-controlled clinical trial of a two-day regimen of dihydroartemisinin-piperaquine for malaria prevention halted for concern over prolonged corrected QT interval.
    Manning J; Vanachayangkul P; Lon C; Spring M; So M; Sea D; Se Y; Somethy S; Phann ST; Chann S; Sriwichai S; Buathong N; Kuntawunginn W; Mitprasat M; Siripokasupkul R; Teja-Isavadharm P; Soh E; Timmermans A; Lanteri C; Kaewkungwal J; Auayporn M; Tang D; Chour CM; Prom S; Haigney M; Cantilena L; Saunders D
    Antimicrob Agents Chemother; 2014 Oct; 58(10):6056-67. PubMed ID: 25092702
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics and electrocardiographic effects of dihydroartemisinin-piperaquine in healthy volunteers.
    Chotsiri P; Wattanakul T; Hoglund RM; Hanboonkunupakarn B; Pukrittayakamee S; Blessborn D; Jittamala P; White NJ; Day NPJ; Tarning J
    Br J Clin Pharmacol; 2017 Dec; 83(12):2752-2766. PubMed ID: 28695570
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prospective observational study to evaluate the clinical safety of the fixed-dose artemisinin-based combination Eurartesim® (dihydroartemisinin/piperaquine), in public health facilities in Burkina Faso, Mozambique, Ghana, and Tanzania.
    Baiden R; Oduro A; Halidou T; Gyapong M; Sie A; Macete E; Abdulla S; Owusu-Agyei S; Mulokozi A; Adjei A; Sevene E; Compaoré G; Valea I; Osei I; Yawson A; Adjuik M; Akparibo R; Ogutu B; Upunda GL; Smith P; Binka F
    Malar J; 2015 Apr; 14():160. PubMed ID: 25885858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Two fixed-dose artemisinin combinations for drug-resistant falciparum and vivax malaria in Papua, Indonesia: an open-label randomised comparison.
    Ratcliff A; Siswantoro H; Kenangalem E; Maristela R; Wuwung RM; Laihad F; Ebsworth EP; Anstey NM; Tjitra E; Price RN
    Lancet; 2007 Mar; 369(9563):757-765. PubMed ID: 17336652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of sudden unexplained death after use of dihydroartemisinin-piperaquine for malaria: a systematic review and Bayesian meta-analysis.
    Chan XHS; Win YN; Mawer LJ; Tan JY; Brugada J; White NJ
    Lancet Infect Dis; 2018 Aug; 18(8):913-923. PubMed ID: 29887371
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety evaluation of fixed combination piperaquine plus dihydroartemisinin (Artekin) in Cambodian children and adults with malaria.
    Karunajeewa H; Lim C; Hung TY; Ilett KF; Denis MB; Socheat D; Davis TM
    Br J Clin Pharmacol; 2004 Jan; 57(1):93-9. PubMed ID: 14678346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of dihydroartemisinin-piperaquine versus artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in Zambian children.
    Nambozi M; Van Geertruyden JP; Hachizovu S; Chaponda M; Mukwamataba D; Mulenga M; Ubben D; D'Alessandro U
    Malar J; 2011 Feb; 10():50. PubMed ID: 21352609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin-piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial.
    Ahmed R; Poespoprodjo JR; Syafruddin D; Khairallah C; Pace C; Lukito T; Maratina SS; Asih PBS; Santana-Morales MA; Adams ER; Unwin VT; Williams CT; Chen T; Smedley J; Wang D; Faragher B; Price RN; Ter Kuile FO
    Lancet Infect Dis; 2019 Sep; 19(9):973-987. PubMed ID: 31353217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Piperaquine-Induced QTc Prolongation Decreases With Repeated Monthly Dihydroartemisinin-Piperaquine Dosing in Pregnant Ugandan Women.
    Hughes E; Wallender E; Kajubi R; Jagannathan P; Ochieng T; Kakuru A; Kamya MR; Clark TD; Rosenthal PJ; Dorsey G; Aweeka F; Savic RM
    Clin Infect Dis; 2022 Aug; 75(3):406-415. PubMed ID: 34864925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of dihydroartemisinin/piperaquine (Artekin) for the treatment of uncomplicated Plasmodium falciparum malaria in Rwandan children.
    Karema C; Fanello CI; van Overmeir C; van Geertruyden JP; van Doren W; Ngamije D; D'Alessandro U
    Trans R Soc Trop Med Hyg; 2006 Dec; 100(12):1105-11. PubMed ID: 16766006
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the QT effect of a combination of piperaquine and a novel anti-malarial drug candidate OZ439, for the treatment of uncomplicated malaria.
    Darpo B; Ferber G; Siegl P; Laurijssens B; Macintyre F; Toovey S; Duparc S
    Br J Clin Pharmacol; 2015 Oct; 80(4):706-15. PubMed ID: 25966781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-Country Evaluation of Safety of Dihydroartemisinin/Piperaquine Post-Licensure in African Public Hospitals with Electrocardiograms.
    Kabanywanyi AM; Baiden R; Ali AM; Mahende MK; Ogutu BR; Oduro A; Tinto H; Gyapong M; Sie A; Sevene E; Macete E; Owusu-Agyei S; Adjei A; Compaoré G; Valea I; Osei I; Yawson A; Adjuik M; Akparibo R; Kakolwa MA; Abdulla S; Binka F
    PLoS One; 2016; 11(10):e0164851. PubMed ID: 27764178
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated malaria in Papua New Guinea.
    Tavul L; Hetzel MW; Teliki A; Walsh D; Kiniboro B; Rare L; Pulford J; Siba PM; Karl S; Makita L; Robinson L; Kattenberg JH; Laman M; Oswyn G; Mueller I
    Malar J; 2018 Oct; 17(1):350. PubMed ID: 30290825
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal study based on a safety registry for malaria patients treated with artenimol-piperaquine in six European countries.
    Vignier N; Bouchaud O; Angheben A; Bottieau E; Calleri G; Salas-Coronas J; Martin C; Ramos JM; Mechain M; Rapp C; Nothdurft HD; Velasco M; Bardají A; Rojo-Marcos G; Visser LG; Hatz C; Bisoffi Z; Jelinek T; Duparc S; Bourhis Y; Tommasini S; Iannucelli M; Bacchieri A; Mattera GG; Merlo Pich E; Behrens RH
    Malar J; 2021 May; 20(1):214. PubMed ID: 33964945
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
    Lwin KM; Phyo AP; Tarning J; Hanpithakpong W; Ashley EA; Lee SJ; Cheah P; Singhasivanon P; White NJ; Lindegårdh N; Nosten F
    Antimicrob Agents Chemother; 2012 Mar; 56(3):1571-7. PubMed ID: 22252804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cluster-randomized trial of monthly malaria prophylaxis versus focused screening and treatment: a study protocol to define malaria elimination strategies in Cambodia.
    Manning J; Lon C; Spring M; Wojnarski M; Somethy S; Chann S; Gosi P; Soveasna K; Sriwichai S; Kuntawunginn W; Fukuda MM; Smith PL; Rekol H; Sinoun M; So M; Lin J; Satharath P; Saunders D
    Trials; 2018 Oct; 19(1):558. PubMed ID: 30326952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrocardiographic safety evaluation of extended artemether-lumefantrine treatment in patients with uncomplicated Plasmodium falciparum malaria in Bagamoyo District, Tanzania.
    Mhamilawa LE; Wikström S; Mmbando BP; Ngasala B; Mårtensson A
    Malar J; 2020 Jul; 19(1):250. PubMed ID: 32664948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monthly sulfadoxine-pyrimethamine versus dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in pregnancy: a double-blind, randomised, controlled, superiority trial.
    Kajubi R; Ochieng T; Kakuru A; Jagannathan P; Nakalembe M; Ruel T; Opira B; Ochokoru H; Ategeka J; Nayebare P; Clark TD; Havlir DV; Kamya MR; Dorsey G
    Lancet; 2019 Apr; 393(10179):1428-1439. PubMed ID: 30910321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.